---
title: "TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/292534080.md"
description: "TherapeuticsMD Inc. (TXMD) shares fell 1.50% to $1.97 on Monday, underperforming competitors like AbbVie during a broad market decline. This marks the second consecutive day of losses for the stock, which remains 33.22% below its 52-week high. Trading volume was significantly lower than the 50-day average."
datetime: "2026-07-13T21:30:54.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/292534080.md)
  - [en](https://longbridge.com/en/news/292534080.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/292534080.md)
---

# TherapeuticsMD Inc. Stock Underperforms Monday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of TherapeuticsMD Inc. (TXMD) slid 1.50% to $1.97 Monday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 1.55% to 25,873.18 and Dow Jones Industrial Average falling 0.26% to 52,498.64.

This was the stock's second consecutive day of losses.

TherapeuticsMD Inc. closed 33.22% short of its 52-week high of $2.95, which the company reached on January 27th.

The stock underperformed when compared to some of its competitors Monday, as AbbVie Inc. (ABBV) fell 0.03% to $248.00.

Trading volume (4,355) remained 38,910 below its 50-day average volume of 43,265.

Data source: Dow Jones Market Data, FactSet. Data compiled July 13, 2026.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

(END) Dow Jones Newswires

07-13-26 1730ET

### Related Stocks

- [TXMD.US](https://longbridge.com/en/quote/TXMD.US.md)
- [.IXIC.US](https://longbridge.com/en/quote/.IXIC.US.md)
- [.DJI.US](https://longbridge.com/en/quote/.DJI.US.md)
- [ABBV.US](https://longbridge.com/en/quote/ABBV.US.md)
- [FDS.US](https://longbridge.com/en/quote/FDS.US.md)

## Related News & Research

- [TherapeuticsMD Q2 FY26 laba bersih turun ke US$ 164.000; revenue lisensi turun ke US$ 864.000](https://longbridge.com/en/news/295572651.md)
- [TherapeuticsMD Inc. Stock Outperforms Competitors On Strong Trading Day](https://longbridge.com/en/news/295019659.md)
- [Pushly Makes the 2026 Inc. 5000 List of Fastest-Growing Private Companies for the Fourth Consecutive Year](https://longbridge.com/en/news/295544615.md)
- [Fort Technology Inc. reports  results](https://longbridge.com/en/news/295961156.md)
- [Focus Financial Network Inc. Buys New Shares in Sezzle Inc. $SEZL](https://longbridge.com/en/news/295502121.md)